Craig A. Stump

647 total citations
11 papers, 264 citations indexed

About

Craig A. Stump is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Craig A. Stump has authored 11 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in Craig A. Stump's work include Migraine and Headache Studies (7 papers), Neuropeptides and Animal Physiology (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Craig A. Stump is often cited by papers focused on Migraine and Headache Studies (7 papers), Neuropeptides and Animal Physiology (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Craig A. Stump collaborates with scholars based in United States and Poland. Craig A. Stump's co-authors include Christopher Salvatore, Scott D. Mosser, Stefanie A. Kane, Ian M. Bell, Theresa M. Williams, Joseph P. Vacca, Diem N. Nguyen, Samuel Graham, Steven N. Gallicchio and C. Blair Zartman and has published in prestigious journals such as Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.

In The Last Decade

Craig A. Stump

11 papers receiving 253 citations

Peers

Craig A. Stump
Wai N. Chan United Kingdom
Ria Wouters Belgium
George Thalody United States
Robert W. Kimball United States
Christine DeVos United States
Aqfan Jamaluddin United Kingdom
Wai N. Chan United Kingdom
Craig A. Stump
Citations per year, relative to Craig A. Stump Craig A. Stump (= 1×) peers Wai N. Chan

Countries citing papers authored by Craig A. Stump

Since Specialization
Citations

This map shows the geographic impact of Craig A. Stump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig A. Stump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig A. Stump more than expected).

Fields of papers citing papers by Craig A. Stump

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig A. Stump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig A. Stump. The network helps show where Craig A. Stump may publish in the future.

Co-authorship network of co-authors of Craig A. Stump

This figure shows the co-authorship network connecting the top 25 collaborators of Craig A. Stump. A scholar is included among the top collaborators of Craig A. Stump based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig A. Stump. Craig A. Stump is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Stump, Craig A., Andrew Cooke, Joseph G. Bruno, et al.. (2016). Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology. Bioorganic & Medicinal Chemistry Letters. 26(23). 5809–5814. 16 indexed citations
2.
Raheem, Izzat T., Michael J. Breslin, Joseph G. Bruno, et al.. (2014). Discovery of piperidine ethers as selective orexin receptor antagonists (SORAs) inspired by filorexant. Bioorganic & Medicinal Chemistry Letters. 25(3). 444–450. 17 indexed citations
3.
Wood, Michael R., Shawn J. Stachel, Craig A. Stump, et al.. (2013). (E)-Alkenes as replacements of amide bonds: Development of novel and potent acyclic CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(1). 258–261. 5 indexed citations
4.
Bell, Ian M., Craig A. Stump, Steven N. Gallicchio, et al.. (2012). MK-8825: A potent and selective CGRP receptor antagonist with good oral activity in rats. Bioorganic & Medicinal Chemistry Letters. 22(12). 3941–3945. 19 indexed citations
5.
Bell, Ian M., Steven N. Gallicchio, Michael R. Wood, et al.. (2010). Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist. ACS Medicinal Chemistry Letters. 1(1). 24–29. 46 indexed citations
6.
Wood, Michael R., Craig A. Stump, Ian M. Bell, et al.. (2009). Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility. Bioorganic & Medicinal Chemistry Letters. 19(19). 5787–5790. 10 indexed citations
7.
Stump, Craig A., Ian M. Bell, Rodney A. Bednar, et al.. (2008). The discovery of highly potent CGRP receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(1). 214–217. 23 indexed citations
8.
Shaw, Anthony W., Daniel V. Paone, Diem N. Nguyen, et al.. (2007). Caprolactams as potent CGRP receptor antagonists for the treatment of migraine. Bioorganic & Medicinal Chemistry Letters. 17(17). 4795–4798. 31 indexed citations
9.
Williams, Theresa M., Craig A. Stump, Diem N. Nguyen, et al.. (2006). Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead. Bioorganic & Medicinal Chemistry Letters. 16(10). 2595–2598. 39 indexed citations
10.
Burgey, Christopher S., Craig A. Stump, Diem N. Nguyen, et al.. (2006). Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: Optimization of the 4-substituted piperidine. Bioorganic & Medicinal Chemistry Letters. 16(19). 5052–5056. 40 indexed citations
11.
Nguyen, Diem N., Craig A. Stump, Eileen S. Walsh, et al.. (2002). Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 12(9). 1269–1273. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026